跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAZAL SPRAY - HSA Drug Approval Details
Approvals
/
HSA
/
NAZAL SPRAY
Approved
THERAPEUTIC
NAZAL SPRAY
SATO PHARMACEUTICAL CO LTD (JAPAN)
🇸🇬 Health Sciences Authority
Approval Date
Nov 6, 1989
Approval ID
1142ffff554ef927
Company
SATO PHARMACEUTICAL CO LTD (JAPAN)
Type
Therapeutic
Approval Details
Approval Id
1142ffff554ef927
Drug Name
NAZAL SPRAY
Product Name
NAZAL SPRAY
Approval Number
SIN03722P
Approval Date
1989-11-06
Registrant
SATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder
SATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SPRAY
Route Of Administration
NASAL
Atc Code
R01AB02
Atc Item Name
naphazoline
Pharma Manufacturer Name
SATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Active Ingredients
CHLORPHENIRAMINE MALEATE
500 mg/100 ml
NAPHAZOLINE HCl
50 mg/100 ml
CHLORPHENIRAMINE MALEATE
500 mg/100 ml
NAPHAZOLINE HCl
50 mg/100 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 6, 1989
Approval ID
1142ffff554ef927
Type
Therapeutic
Back to HSA Approvals